Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Tele2 first in Sweden to offer 5G roaming

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) today launches the first 5G roaming agreement on the Swedish and Latvian market, between Tele2 Sweden and Tele2 Latvia. This means that roaming will be available for all Tele2’s 5G customers starting today, June 2 2020.Tele2 switched on Sweden’s first public 5G network on May 24 2020, which enables Tele2 customers with a Tele2 Unlimited subscription and a 5G ready phone to get free access to 5G. Today Tele2 launches the first 5G roaming agreement, between Tele2 Sweden and Tele2 Latvia, and by that becomes the first

SOTKAMO SILVER: STARTS PILOT TESTING OF ORE SORTER

Press release June 2 2020, Stockholm 08:45 Sotkamo Silver has started the pilot testing of the Ore Sorting in May. The Ore Sorter has been supplied and successfully commissioned at the Silver Mine by Outotec and Tomra. The Ore Sorter uses X-Ray Transmission (XRT) technology to scan every feed particle and to identify the relative atomic density differences within particles and then separates desired high-grade particles from the barren material pneumatically. Sorting of marginal ore is done after primary crushing and it is expected to reduce roughly 50% of non-ore material going into the

Vator Securities: Xbrane Biopharma: Pop up on your boards – “the third wave” of biosimilars is rather a tsunami.

Xbrane provides an exceptionally attractive exposure to the rapidly growing biosimilars market without the significant clinical and approval risk that is often present in biotech companies. 2019 proved to be a real tipping point with rapid uptake of the more recent biosimilar launches. It is nowadays  trivial to question the attractiveness of the biosimilar market opportunity; the interesting question is rather which players have the best fit to capture this opportunity. We believe that Xbrane stands well-positioned for this with Xlucane progressing through the low-risk pivotal phase III

SRV Group Plc: Managers' transactions – Ursula Ranin

SRV GROUP PLC       MANAGERS' TRANSACTIONS   2 JUNE 2020     9.35 EET SRV Group Plc: Managers' transactions – Ursula Ranin Notification under the EU Market Abuse Regulation, article 19 SRV Yhtiöt Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Ranin, Silja Katri Ursula Position: Closely associated person (1):Person Discharging Managerial Responsibilities In Issuer Name: Kallasvuo, Olli-Pekka Position: Member of the Board Issuer: SRV Yhtiöt Oyj LEI: 743700GB29FXC0VXF414

Seven quick questions about air cargo for Ylva Arvidsson, Head of Swedavia’s air cargo operations

Ylva Arvidsson, Swedavia’s Director of Cargo, believes there is pent-up demand for air cargo and that air cargo can play an important role in the recovery of the aviation industry and of the world’s economies. What role and what importance does air cargo have?“Air cargo accounts for about 1 per cent of global transport. On the other hand, it accounts for about 35 per cent of the value of goods that are transported. The high-value goods that are flown include medicines, vaccines, medical devices, spare parts, components, perishable foods and goods that have a short product life cycle

Changes in Alfa Laval Group Management

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – today announces that Peter Torstensson, Senior Vice President and Head of Global Marketing & Communications, has decided to retire as of July 1, 2020.“Peter has played a key strategic role in the company over more than 20 years,” says Tom Erixon, President and CEO of the Alfa Laval Group. “In that time period Alfa Laval has developed into a world leader in many applications, supporting our customers to transit into more sustainable business models. Peter’s branding and strategic communication expertise

The subscription period in Initiator Pharma’s rights issue begins today

Today, on the 2[nd] of June 2020, the subscription period for Initiator Pharma A/S ("Initiator Pharma" or "the Company") rights issue of units begins. The subscription period runs until the 16[th ]of June 2020. A fully subscribed issue of units and utilized warrants issued in this rights issue will provide Initiator Pharma with a total of approximately MSEK 17.4 (before issue costs amounting to MSEK 1.2 incl. guarantee compensation), of which approximately MSEK 6.96 represents the initial part of the issue and approximately MSEK 10.44 represents the warrants of series TO 2. Prior to the

SRV Group Plc: Managers' transactions – Olli-Pekka Kallasvuo

SRV GROUP PLC       MANAGERS' TRANSACTIONS   2 JUNE 2020     9.30 EET SRV Group Plc: Managers' transactions – Olli-Pekka Kallasvuo Notification under the EU Market Abuse Regulation, article 19 SRV Yhtiöt Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Kallasvuo, Olli-Pekka Position: Member of the Board/Deputy member Issuer: SRV Yhtiöt Oyj LEI: 743700GB29FXC0VXF414 Notification type: INITIAL NOTIFICATION Reference number: 743700GB29FXC0VXF414_20200601125502_4 ____________________

Nordic winners ready for EY World Entrepreneur Of The Year 2020

This year, the world’s largest program of its kind; EY World Entrepreneur Of The Year  is going virtual. On 4 June, finalists from 31 countries will compete online - and ultimately one winner will become EY World Entrepreneur Of The Year 2020. The international finals are the culmination of regional events in 150 cities around the world.“More than ever given these unprecedented times, it is important to learn from and recognize the unstoppable entrepreneurs who have a significant impact on the economy, on job creation, on innovation and on their communities and

Dividend amount in XACT Sverige (UCITS ETF)

The dividend amount of the above stated Exchange Traded Fund is SEK 19.90 per fund unit. Registered holder of fund units on the record day will receive dividend.   The schedule for the dividend is as follows: June 8         Last day to trade fund units including the right to receive dividendJune 9         Ex-dividend; the fund units are traded ex dividendJune 10       Record dayJune 15       Payment day For further information, please contact: Magdalena Wahlqvist Alveskog, CEO Handelsbanken Fonder AB:  +46 (0)8 701 15 55 This information is of the type that

Nordic Nanovector to Present at Upcoming Jefferies Virtual Healthcare Conference and ABG Sundal Collier Virtual Oncology Seminar

Oslo, Norway, 2 June 2020 Nordic Nanovector ASA (OSE: NANO) announces that members of its management team will present at Jefferies Virtual Healthcare Conference, taking place 2-4 June 2020. Nordic Nanovector will also present at ABG Sundal Collier Virtual Oncology Seminar 10 June 2020. Presentations details are as follows: Jefferies Virtual Healthcare ConferenceDate: Tuesday, 2 June 2020Time: 16:30 CET ABG Sundal Collier Virtual Oncology SeminarDate: Wednesday, 10 June 2020Time: 10:25 CET The company presentation will be available on Nordic Nanovector’s Investors

NCC to construct section of Tvärbanan light rail line

NCC has been commissioned by Stockholm Public Transport (SL) and the City of Sundbyberg to carry out preparatory work for the Tvärbanan light rail line by the new Rissne station in the north of Stockholm. The order value is approximately SEK 265 million. Image: NCCThe Tvärbanan’s Kista line will run between Ulvsunda and Helenelund and will include ten new stations across three municipalities: Stockholm, Sundbyberg and Sollentuna. Next to the Rissne station, NCC has been commissioned to perform preparatory works featuring technically complex elements. NCC will carry out

Read original

Zwipe appoints new Executive Vice President Strategy & Channels

OSLO, NORWAY– 02 June 2020 – Zwipe AS announces that Bishwajit Choudhary has accepted the position of Executive Vice President Strategy & Channels at Zwipe, commencing 2 June 2020.  He will lead Zwipe’s engagement efforts towards banks, global and domestic card schemes, selected retailers and other important payments ecosystem stakeholders. Based in Oslo, Mr. Choudhary brings two decades of experience from Nets where he led many new business initiatives within Digital-ID, electronic signatures and mobile authentication for international clients. As the Group SVP (Strategy) he led Nets'

SKF factories to be carbon neutral by 2030

Gothenburg, 2 June 2020: Since 2015, SKF has decreased its manufacturing carbon footprint by 36% and is already operating two carbon neutral factories. Today, SKF announces its aim to achieve a fully carbon neutral manufacturing footprint by 2030. The 2030 target will cover SKF’s own manufacturing operations, i.e. SKF’s scope 1 and 2 emissions. It will be achieved by a combination of process improvements, energy efficient machinery, and procurement and generation of renewable energy. As a last resort, SKF may also purchase high quality carbon offsets. Alrik Danielson, President and

Systemair's Interim Report for the fourth quarter will be presented on June 9

Press Release, 2 June 2020 Systemair ABs (NASDAQ OMX Stockholm: SYSR) Interim Report Q4 for the financial year 2019/20 will be published at 08:00 CET on June 9, 2020. A telephone conference will be held at 09:00 CET on June 9, 2020. The report will be presented by Roland Kasper, CEO, and Anders Ulff, CFO. In order to participate in the telephone conference:Call +46 8 566 426 51 alternative 0200 883 685 and enter code 95682375# minutes before start. The presentation will be published on group.systemair.com For further information contact:Roland Kasper, CEO, + 46 73 094 40

Miss Group announced winners of the Northern Tech Awards 2020 as the Fastest Growing Tech Company

Miss Group was announced as the fastest growing tech company at the Northern Tech Awards 2020 on 27th May. Presented by GP Bullhound, this virtual event was attended by hundreds of entrepreneurs, investors and business leaders from the global tech community.Mattias Kaneteg, founder and CEO of Miss Group, accepted the award from Edie Lush, an international technology journalist and author, who highlighted the + 200% revenue growth reported by Miss Group between 2017 and 2019. The audience heard that this had been achieved through both organic growth and acquisitions, and with financing

SynAct Pharma´s clinical trial application for AP1189 in Nephrotic Syndrome approved by the Danish Medical Agency

SynAct Pharma AB ("SynAct") today announced that the Danish Medical Agency has approved the company’s clinical trial application (CTA) for a Phase IIa study in idiopathic membranous nephropathy patients with Nephrotic Syndrome.In the Phase IIa study, AP1189 will be tested in a double-blind, placebo-controlled multicentre study as add-on therapy to ACE-inhibitor or Angiotensin-2 receptor antagonists in a once-daily dose regimen for four weeks with the primary purpose to show treatment effect on urinary protein excretion relative to pre-treatment levels and placebo. The patients will be dosed

Kallelse till årsstämma i Nilar International AB (publ) / Notice of annual general meeting in Nilar International AB (publ)

Aktieägarna i Nilar International AB, org. nr 556600-2977, ("Bolaget") kallas härmed till årsstämma tisdagen den 30 juni 2020 kl. 16.00 i Baker & McKenzie advokatbyrås lokaler på Vasagatan 7 i Stockholm. The shareholders of Nilar International AB, reg. no. 556600-2977, (the "Company"), are hereby convened to the annual general meeting to be held on Tuesday 30 June 2020, at 16.00 at Baker & McKenzie’s premises on Vasagatan 7 in Stockholm, Sweden.

Oncoinvent Announces Dosing of First Patient with Radspherin[® ]in Phase 1 Clinical Trial

Radiopharmaceutical company starts first-in-human trial in colorectal patients suffering from peritoneal carcinomatosisOncoinvent AS, a clinical stage radiopharmaceutical company developing novel radioisotope-based therapies to provide new therapeutic options for cancer patients, today announced that the first patient has been dosed in the phase 1, first-in-human clinical trial of it’s lead candidate compound Radspherin[®]. “Radspherin[®] represents a promising new approach for treating patients with metastates to the peritoneal cavity from colorectal cancer that may potentially provide

BERGENBIO CONFIRMS FIRST COVID19 PATIENT DOSED WITH BEMCENTINIB IN ACCORD TRIAL

Bergen, Norway – 02 June 2020: BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, today announces that dosing has commenced in the UK Government-backed Phase II clinical trial assessing bemcentinib in hospitalised COVID-19 patients. Bemcentinib was selected as the first candidate to be tested as part of the ACcelerating COVID-19 Research & Development platform (ACCORD) study, launched by the Department of Health and Social Care (DHSC) and UK Research and Innovation (UKRI) on 28[th] April

Seadrill Limited (SDRL) - First Quarter 2020 Results

Material impairments on assets and investments and a focus on restructuringHighlights ·Revenue down 19% at $321 million with lower proportion of reimbursable revenues ·Technical utilization of 95% and economic utilization of 93% ·Operating Loss of $1,284 million after making material asset impairments ·Adjusted EBITDA of $55 million, representing 17.1% margin ·Net loss attributable to shareholder of $1,564 million equivalent to net loss per share of $15.59 ·During the quarter we added $77 million in backlog, maintaining a total backlog figure of $2.

Sustainable production methods and traceability of materials for battery manufacturing

Press release 2.6.2020  The success of electric cars on the markets may be determined by production methods and origin information of battery materials in the future. VTT and Geological Survey of Finland GTK launched a three-year project with their industrial partners to promote the sustainable production methods and traceability of battery materials. A promising starting point for tracing the origin is offered by the fingerprint conserved in the metals, which may directly tell where the metals were mined.When examining transport emissions, electric cars using renewable electricity

Camurus announces submission of request for final approval of Brixadi™ for the treatment of opioid use disorder in the US

Lund, Sweden — 1 June 2020 — Camurus AB (NASDAQ STO: CAMX) today announces that the company’s US partner Braeburn has submitted a request for final approval of Brixadi™ (buprenorphine) weekly and monthly extended release injection for the treatment of opioid use disorder to the US Food and Drug Administration (FDA). On 21 December 2018, Brixadi (the US trade name for Buvidal[®]) was tentatively approved by the FDA, having met all regulatory requirements regarding efficacy, safety and quality. However, Brixadi was not eligible for marketing in the US because of an exclusivity period

There are no items matching the current filter
There are no more items matching the current filter
Back to top